Treatment of hepatitis C virus related diseases using hydroxychloroquine or a combination of hydroxychloroquine and an anti-viral agent
AssigneesPanmed Ltd., Genoscience Pharma
InventorPhilippe Halfon
Life of this patent
Estimating the term…
Abstract
Methods of treating a hepatitis C virus (HCV) related disease, such as HCV infections in subjects non-responsive to anti-HCV therapy, are described herein, comprising administering to the subject a therapeutically effective amount of hydroxychloroquine. An antiviral agent may be co-administered with the hydroxychloroquine. Methods utilizing synergistic combinations of hydroxychloroquine and an antiviral agent are disclosed. Further disclosed are compositions comprising hydroxychloroquine and an antiviral agent, as well as hydroxychloroquine and uses thereof for the treatment of a hepatitis C virus (HCV) related disease.
Claims7
A pharmaceutical composition comprising hydroxychloroquine or a pharmaceutically acceptable salt thereof, an antiviral agent, and a pharmaceutically acceptable carrier, the composition being identified for use in the treatment of a hepatitis C virus (HCV) infection in an HCV-infected subject non-responsive to an anti-HCV therapy, wherein said antiviral agent is ribavirin.
Dependencies are inferred from the claim text.